Glucocorticoids and treatment of prostate cancer: A preclinical and clinical review

[31] Nishiyama T, 1998, Int J Urol, V5, P44, DOI 10.1111/j.1442-2042.1998.tb00233.x

[32] Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1654 - 1663

[33] PATEL SR, 1990, CANCER-AM CANCER SOC, V66, P655, DOI 10.1002/1097-0142(19900815)66:4<655::AID-CNCR2820660409>3.0.CO

[34] 2-P

[35] LIPOCORTIN-DERIVED PEPTIDES [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 47 (06) : 931 - 938

[36] ANDROGEN SUPPRESSION BY HYDROCORTISONE WITHOUT AMINOGLUTETHIMIDE IN ORCHIECTOMIZED MEN WITH PROSTATIC-CANCER [J]. BRITISH JOURNAL OF UROLOGY, 1987, 59 (03): : 255 - 257

[37] AN AMINO-TERMINAL FRAGMENT OF UROKINASE ISOLATED FROM A PROSTATE-CANCER CELL-LINE (PC-3) IS MITOGENIC FOR OSTEOBLAST-LIKE CELLS [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 173 (03) : 1058 - 1064

[38] Glucocorticoid receptor function possibly modulates cell-cell interactions in osteoblastic metastases on rat skeleton [J]. CLINICAL & EXPERIMENTAL METASTASIS, 1997, 15 (03) : 205 - 217

[39] Riccardi C, 2000, THERAPIE, V55, P165

[40] Roberts A.B., 1990, PEPTIDE GROWTH FACTO, P419

[31] Nishiyama T, 1998, Int J Urol, V5, P44, DOI 10.1111/j.1442-2042.1998.tb00233.x

[32] Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1654 - 1663

[33] PATEL SR, 1990, CANCER-AM CANCER SOC, V66, P655, DOI 10.1002/1097-0142(19900815)66:4<655::AID-CNCR2820660409>3.0.CO

[34] 2-P

[35] LIPOCORTIN-DERIVED PEPTIDES [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 47 (06) : 931 - 938

[36] ANDROGEN SUPPRESSION BY HYDROCORTISONE WITHOUT AMINOGLUTETHIMIDE IN ORCHIECTOMIZED MEN WITH PROSTATIC-CANCER [J]. BRITISH JOURNAL OF UROLOGY, 1987, 59 (03): : 255 - 257

[37] AN AMINO-TERMINAL FRAGMENT OF UROKINASE ISOLATED FROM A PROSTATE-CANCER CELL-LINE (PC-3) IS MITOGENIC FOR OSTEOBLAST-LIKE CELLS [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 173 (03) : 1058 - 1064

[38] Glucocorticoid receptor function possibly modulates cell-cell interactions in osteoblastic metastases on rat skeleton [J]. CLINICAL & EXPERIMENTAL METASTASIS, 1997, 15 (03) : 205 - 217

[39] Riccardi C, 2000, THERAPIE, V55, P165

[40] Roberts A.B., 1990, PEPTIDE GROWTH FACTO, P419